Your session is about to expire
← Back to Search
Nerve Blocks for Breast Reconstruction
N/A
Recruiting
Led By Kathryn Isaac, MD MPH FRCSC
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must be female, and at least 19 years old.
Patients must be ASA grade I or II.
Must not have
Patients weighing less than 50kg.
Patients have a known contraindication for a regional block: known coagulation disorder, treatment with anticoagulants, infection at the injection site, known allergy to medication in the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Summary
This trial is testing if adding an extra pain relief method (Pecs block) to the usual method (TPVB block) helps reduce pain better for patients undergoing mastectomy with immediate breast reconstruction. The treatment works by numbing specific areas to block pain signals. Pectoralis nerve (Pecs) blocks have been shown to reduce the need for opioids during surgery in patients undergoing mastectomies.
Who is the study for?
This trial is for women over 19 years old undergoing mastectomy with immediate breast reconstruction using tissue expanders or implants. They should be in good health (ASA grade I or II) and not too far from the hospital. It's not for those under 50kg, BMI over 35, pregnant, having bilateral reconstructions at once, on anticoagulants, with bleeding disorders, infections at injection sites, allergies to study meds or poor overall health (ASA III/IV).
What is being tested?
The trial tests pain management techniques in breast surgery recovery. It compares a Thoracic paravertebral block (TPVB) combined with Pecs II local anesthetic block against TPVB with a sham Pecs II saline block. The focus is on acute and chronic pain levels, opioid use and side effects, patient recovery quality reports and hospital stay duration.
What are the potential side effects?
Potential side effects may include discomfort at the injection site of the nerve blocks used for anesthesia during surgery which could lead to infection if proper care isn't taken post-operation. Opioid-related side effects might occur due to medication consumption.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman and I am 19 years old or older.
Select...
I am in good or mild systemic disease condition.
Select...
I am having a full breast removal with immediate reconstruction using an implant or tissue expander.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I weigh less than 50kg.
Select...
I cannot have a regional block due to a bleeding disorder, medication I'm on, infection, or allergy to the study drug.
Select...
I am having both breasts removed and reconstructed with implants at the same time.
Select...
I have a serious health condition but am not at immediate risk of death.
Select...
My BMI is over 35.
Select...
I live more than an hour's drive from the hospital.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average pain score in the 24-hour post-operative period assessed by the Numerical Rating Scale.
Rate of participant recruitment
Rate of participant retention
+1 moreSecondary study objectives
Acute patient-reported pain scores assessed by the Numerical Rating Scale
Length of stay in hospital in hours
Number of participants requiring rescue opioid analgesics and anti-emetics.
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Local anesthetic TPVB + Local anesthetic Pecs blockExperimental Treatment2 Interventions
Patients will receive a thoracic paravertebral with pecs block, both with local anesthetic infiltrate.
Group II: Local anesthetic TPVB + Sham Pecs blockPlacebo Group2 Interventions
Patients will receive a thoracic paravertebral with local anesthetic infiltrate and a pecs block with saline infiltrate.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pecs block
2020
N/A
~160
Thoracic paravertebral block
2020
Completed Phase 3
~1010
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Regional anesthesia, such as the TPVB (Thoracic Paravertebral Block) combined with Pecs (Pectoral Nerve Block), works by blocking nerve signals in specific areas of the body to provide targeted pain relief. This is achieved through the injection of local anesthetics near the nerves, which inhibits the transmission of pain signals to the brain.
For plastic surgery patients, this approach is crucial as it can significantly reduce postoperative pain, minimize the need for opioids, and enhance recovery by allowing for better pain management and fewer side effects. Effective pain control is essential for improving patient comfort, reducing hospital stays, and facilitating quicker return to normal activities.
Local anesthetics and regional anesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children: A Cochrane systematic review and meta-analysis update.Post-mastectomy cancer recurrence with and without a continuous paravertebral block in the immediate postoperative period: a prospective multi-year follow-up pilot study of a randomized, triple-masked, placebo-controlled investigation.
Local anesthetics and regional anesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children: A Cochrane systematic review and meta-analysis update.Post-mastectomy cancer recurrence with and without a continuous paravertebral block in the immediate postoperative period: a prospective multi-year follow-up pilot study of a randomized, triple-masked, placebo-controlled investigation.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,466 Previous Clinical Trials
2,485,426 Total Patients Enrolled
Kathryn Isaac, MD MPH FRCSCPrincipal InvestigatorUniversity of British Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman and I am 19 years old or older.I weigh less than 50kg.I cannot have a regional block due to a bleeding disorder, medication I'm on, infection, or allergy to the study drug.I am having both breasts removed and reconstructed with implants at the same time.I am in good or mild systemic disease condition.I am having a full breast removal with immediate reconstruction using an implant or tissue expander.I have a serious health condition but am not at immediate risk of death.My BMI is over 35.I live more than an hour's drive from the hospital.
Research Study Groups:
This trial has the following groups:- Group 1: Local anesthetic TPVB + Local anesthetic Pecs block
- Group 2: Local anesthetic TPVB + Sham Pecs block
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger